Health IT, Hospitals, Startups

IBM and Israeli hospital establish digital health accelerator

The program from IBM Israel and Hadassah Medical Center, which will begin in the first quarter of 2019 and last six months, is open to startups that have completed a post-seed round of financing, according to Israeli publication Globes.

IBM Israel and Hadassah Medical Center in Jerusalem have set up an accelerator that will allow startups to develop digital health tools, solutions and services, according to Israeli publication Globes.

The news was unveiled at an event regarding the eighth class of the IBM Alpha Zone accelerator, which focuses on areas like IoT, security and big data analytics. It’s open to startups innovating in healthcare, retail, travel and transportation, energy and utilities, telecommunications and media. One previous Alpha Zone participant is Nutrino Health, which was acquired by Medtronic last month.

As for the new program from IBM and Hadassah, it is set to begin in the first quarter of 2019 and will last six months. It’s open to startups that have completed a post-seed round of financing. Participating companies will receive access to resources and medical expertise from Hadassah, while IBM will offer the startups technology advice and access to services like hosting on IBM Cloud.

Hadassah Medical Center said it was drawn to IBM because of IBM Alpha Zone’s experience in digital health.

“Working with IBM will propel development to the forefront of advanced medicine internationally and constitute an additional element in realizing Hadassah’s vision of leading the medicine of the future,” said Tamar Raz, CEO of Hadassah Medical Center’s technology transfer company Hadasit, according to Globes.

The accelerator will be built on the premises of the Biohouse technology incubator in the Hadassah Ein Kerem Medical Center. Additionally, it will be supported by the Jerusalem Development Authority, an agency of the Israeli government and the Jerusalem Municipality that promotes the development of the city of Jerusalem.

sponsored content

A Deep-dive Into Specialty Pharma

A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.

Photo: a-image, Getty Images